Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa.
Hepatocyte growth factor/scatter factor (HGF/SF) is a multifunctional cytokine that is involved in many normal as well as pathological conditions. HGF/NK1, a splice variant of HGF/SF, has been reported to have either antagonistic or agonistic effects with regard to c-Met signaling depending on the cell type. In these experiments, we have determined that HGF/NK1 is a potent mitogen for rat hepatocytes in culture. Furthermore, we have found that coagulation factor Xa (fXa) is capable of cleaving HGF/NK1 and single chain HGF/SF (scHGF/SF). The products resulting from cleavage of HGF/NK1 or scHGF/SF by fXa appear as single bands under non-reducing conditions. The reaction products from the digestion of HGF/NK1 by fXa were separated under reducing conditions, and the cleavage site, as determined by N-terminal sequencing, was located C-terminal to arginine 134. Previous work established that the heparin-binding domain for HGF/SF is located in the N domain of HGF/SF. Additionally, the dimerization of the HGF/SF receptor (c-Met) by the ligand HGF/NK1 is facilitated by heparin and related sulfonated sugars on the cell surface, whereas heparin is not required for HGF/SF-mediated dimerization. Cleavage of single chain HGF/SF or HGF/NK1 by factor Xa does not alter the affinity of the respective molecules for heparin, but it did variably affect the associated mitogenic activity of these factors. The associated mitogenic activity of HGF/NK1 was reduced by more than 90%, whereas the mitogenic activity of scHGF/SF was unaffected. This suggests mandatory maintenance of a steric interaction of the N domain and the first kringle domain for HGF/NK1 to act as an agonist for rat hepatocyte growth but is not required by full-length HGF/SF.
Pediaditakis
Peter
P
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261.
Monga
Satdarshan P S
SP
Mars
Wendy M
WM
Michalopoulos
George K
GK
D017398:Alternative Splicing; D000818:Animals; D001120:Arginine / Q000737:chemistry; D001665:Binding Sites; D002478:Cells, Cultured; D019281:Dimerization; D004305:Dose-Response Relationship, Drug; D015951:Factor Xa / Q000378:metabolism*; D006493:Heparin / Q000737:chemistry; D017228:Hepatocyte Growth Factor / Q000235:genetics* / Q000378:metabolism*; D022781:Hepatocytes / Q000378:metabolism; D008024:Ligands; D008297:Male; D008934:Mitogens; D008958:Models, Molecular; D011485:Protein Binding; D020033:Protein Isoforms; D017434:Protein Structure, Tertiary; D051381:Rats; D011916:Rats, Inbred F344; D013997:Time Factors
D008024:Ligands; D008934:Mitogens; D020033:Protein Isoforms; D017228:Hepatocyte Growth Factor; D006493:Heparin; D001120:Arginine; D015951:Factor Xa